Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

780 results about "Sequence alignment" patented technology

In bioinformatics, a sequence alignment is a way of arranging the sequences of DNA, RNA, or protein to identify regions of similarity that may be a consequence of functional, structural, or evolutionary relationships between the sequences. Aligned sequences of nucleotide or amino acid residues are typically represented as rows within a matrix. Gaps are inserted between the residues so that identical or similar characters are aligned in successive columns. Sequence alignments are also used for non-biological sequences, such as calculating the distance cost between strings in a natural language or in financial data.

Systems and methods to detect copy number variation

In one aspect, a system for implementing a copy number variation analysis method, is disclosed. The system can include a nucleic acid sequencer and a computing device in communications with the nucleic acid sequencer. The nucleic acid sequencer can be configured to interrogate a sample to produce a nucleic acid sequence data file containing a plurality of nucleic acid sequence reads. In various embodiments, the computing device can be a workstation, mainframe computer, personal computer, mobile device, etc.
The computing device can comprise a sequencing mapping engine, a coverage normalization engine, a segmentation engine and a copy number variation identification engine. The sequence mapping engine can be configured to align the plurality of nucleic acid sequence reads to a reference sequence, wherein the aligned nucleic acid sequence reads merge to form a plurality of chromosomal regions. The coverage normalization engine can be configured to divide each chromosomal region into one or more non-overlapping window regions, determine nucleic acid sequence read coverage for each window region and normalize the nucleic acid sequence read coverage determined for each window region to correct for bias. The segmentation engine can be configured to convert the normalized nucleic acid sequence read coverage for each window region to discrete copy number states. The copy number variation identification engine can be configured to identify copy number variation in the chromosomal regions by utilizing the copy number states of each window region.
Owner:LIFE TECH CORP

Method for detecting variation of copy numbers of genomes

The invention relates to a method for detecting the variation of copy numbers of genomes. The method specifically comprises the following steps: sequencing sample genomes to obtain genome sequences; aligning the sequences to a reference genome to obtain the positions of the sequences on the genome; dividing the reference genome into windows with a certain length and carrying out statistics on the sequences and basic groups falling on the windows; correcting the windows according to the sequences and GC contents of the basic groups; determining threshold values with normal copy numbers, scanning the windows and determining whether the copy numbers of the windows varies; and precisely scanning the abnormal windows to determine the precise breakpoints and then determine the specific variation position of the copy numbers. According to the method, the sensitivity of the detection for the variation of the copy numbers of the genomes can be improved through utilizing three mean values, carrying out window correction, determining the threshold values with normal copy numbers, precisely scanning the abnormal windows and determining the precise breakpoints and the specific variation positions of the copy numbers; and the method is easy, simple and feasible to operate, high in efficiency, low in cost and beneficial for popularization and application.
Owner:YIKON GENOMICS SHANGHAI CO LTD

Method for detecting mutation information in multiplex amplification sequencing product of genome

The invention discloses a method for detecting mutation information in a multiplex amplification sequencing product of a genome. The method comprises steps as follows: sequencing data are subjected to quality assessment and preprocessing; a recognizable sequencing sequence is selected for sequence assembling; the recognizable sequencing sequence or a sequence obtained through assembling is compared with a reference gene sequence, and preliminary variation information is obtained; fine calibration of sequence variation is performed according to different types of conditions; a calibrated sequencing fragment is obtained; the homozygosis or heterozygosis state of a target fragment is obtained according to the type of the sequencing fragment with the highest abundance; finally, the mutation information in the multiplex amplification sequencing product of the genome is obtained. By means of the method, the amplification product can be rapidly, efficiently and accurately recognized, and the calculation resources are saved; the sequence assembling process is compatible, and the problem of reduction of the quality value of basic groups produced in the sequencing process can be effectively solved; the homozygosis/heterozygosis state of variation information can be more effectively and stably judged, and random errors introduced in the PCR (polymerase chain reaction) process and the sequencing process are eliminated.
Owner:AMOY DIAGNOSTICS CO LTD +1

Method and device for simultaneously determining fetal nucleic acid content and aneuploidy of chromosome

The invention provides a method for determining the fetal nucleic acid content of a body liquid sample of a pregnant woman, a method for simultaneously determining the fetal nucleic acid content of the body liquid sample of the pregnant woman and variation information of fetal chromosome, a non-diagnosis method for detecting fetal nucleic acid mutation in the body liquid sample of the pregnant woman and respective devices. The method for determining the fetal nucleic acid content of the body liquid sample of the pregnant woman comprises the steps of obtaining the body liquid sample of the pregnant woman; extracting a first DNA and a second DNA from the sample, wherein the first DNA is a mixture of the DNA of the mother and the DNA of a fetus, and the second DNA is a genome DNA of the mother; sequencing the first DNA of at least one part and the second DNA of at least one part so as to obtain a first reading section and a second reading section which comprise a plurality of polymorphic sites; respectively comparing the first reading section and the second reading section with a reference sequence, and screening out a polymorphic site, which has one genotype in the second DNA and has two genotypes in the first DNA, from the multiple polymorphic sites according to an obtained comparison result; determining the fetal nucleic acid content of the sample according to the quantity of the reading sections, which support the screened polymorphic site, in the first reading section in the comparison result.
Owner:TIANJIN MEDICAL LAB BGI +2

Low allergenic protein variants

The present invention relates to a method of selecting a protein variant having reduced immunogenicity as compared with the parent protein. This method includes the steps of screening a random peptide display package library with antibodies raised against any protein of interest, sequencing the amino acid sequence of the antibody binding peptides, or the DNA sequence encoding the antibody binding peptides, identifying epitope patterns of a protein by sequence alignment of the reactive peptide sequence, localization of epitope patterns on the primary 3-dimensional structure of the parent protein, defining an epitope area including amino acids situated within 5 Å from the epitope amino acids, and affecting antibody binding to the epitope, changing the localized epitope patterns, or amino acids defining the epitope area of the parent protein by genetic engineering mutations of a DNA sequence encoding the parent protein without impairing functionality of the protein using the emerging epitode database for eliminating amino acid substitutions creating new or duplicating existing epitope patterns, introducing the mutated DNA sequence into a suitable host, culturing the host and expressing the protein variant, and evaluating the immunogenicity of the protein variant using the parent protein as reference. The invention further relates to the protein variant and its use, as well as to a method for producing said protein variant.
Owner:NOVOZYMES AS

Method and device for quick contrast and analysis of short sequence for second-generation sequencing

The invention discloses a method and a device for quick contrast and analysis of a short sequence for second-generation sequencing, which can solve the problems of low contrast efficiency and high memory occupation ratio of sequencing data. The method comprises the following steps of obtaining a DNA (deoxyribonucleic acid) short sequence obtained by sequencing, and respectively mapping and encoding the DNA short sequence by a first hash algorithm and a second hash algorithm, so as to respectively obtain a first index and a second index; according to a preset index query library, the first index and the second index, contrasting the DNA short sequence and a reference gene group, wherein the index query library consists of an unit structure array, and each unit structure comprises value and index 2; storing the array index offset of each unit structure as the corresponding index 1, namely the index value corresponding to the structure array, wherein K is the length of segment sequence; according to the contrast result, when the contrast result is correct, obtaining the value of the K-mer segment contrasted with the corresponding DNA short sequence, and determining the chromosome number of the corresponding DNA short sequence and the site on the chromosome.
Owner:北京普康瑞仁医学检验所有限公司

Speed detection method based on license plate characteristic matching

InactiveCN105551264ASolve the problem of insufficient matching accuracySolve instabilityRoad vehicles traffic controlCharacter and pattern recognitionAlgorithmTime difference
The invention provides a speed detection method based on license plate characteristic matching. The method comprises the following steps of 1) delimiting a first detection area and a second detection area and setting a triggering line; 2) when the triggering line is triggered, carrying out coarse positioning on a license plate area and carrying out identification of true and false; 3) carrying out character segmentation on a positioned license plate and carrying out character identification; 4) storing an identified character sequence and taking as a matching characteristic, and recording a position coordinate of a license plate center and a current frame number; 5) using a character sequence detected in the second detection area to compare with a license plate record in the first detection area, calculating a distance through converting a pixel coordinate into a real coordinate, according to the frame number, acquiring a time difference so as to calculate a speed. The license plate adopted in the invention is served as a characteristic of vehicle matching and a problem that matching precision is insufficient by using a speed measurement method based on characteristic point characteristic matching can be effectively solved. And through recording the license plate characteristic of each area and current position information, an unstable problem existing in multi-vehicle speed measurement can be solved.
Owner:SHANGHAI ADVANCED RES INST CHINESE ACADEMY OF SCI

Application of nucleotide sequence of rDNA (recombinant deoxyribonucleic acid) ITS (internal transcribed spacer)-D3 region in establishment of DNA (deoxyribonucleic acid) bar code identification system for medicinal plants

The invention relates to a method for identifying medicinal plants by utilizing nucleotide sequences, in particular to an application of a nucleotide sequence of an rDNA (recombinant deoxyribonucleic acid) ITS (internal transcribed spacer)-D3 region in establishment of a DNA (deoxyribonucleic acid) bar code identification system for medicinal plants. The application comprises the following steps of: firstly, detecting the nucleotide sequences of the ITS-D3 regions of medicinal plants, and establishing a DNA bar code database; then, detecting the nucleotide sequence of the ITS-D3 region of a sample to be identified; constructing a clustering tree by the detected nucleotide sequence and the nucleotide sequences of the ITS-D3 regions in the DNA bar code database; determining the medicinal plant having the closest genetic relationship with the sample to be identified in the DNA bar code database according to the clustering tree, and comparing the difference between the nucleotide sequences of the ITS-D3 regions of the medicinal plant and the sample to be identified; and then, by taking the name of the species of the medicinal plant having the closest genetic relationship with the sample to be identified in the database as a reference and combining information such as morphological characteristics and the like, determining the name of the species of the sample to be identified. In the invention, the DNA bar codes have the characteristics of good primer universality, accurate sequence comparison and strong species distinguishing capability.
Owner:GUANGZHOU UNIVERSITY OF CHINESE MEDICINE +1

Detection device and method for gene fusion

The invention discloses a detection device and method for gene fusion. The detection method is executed between sequence alignment and local assembly verification and comprises the step of local sequence clustering. The method for local sequence clustering comprises the steps that local clustering is conducted on a second A type sequence which is partially matched with a first position and is also partially matched with a second position of a reference genome and a second B type sequence which is partially matched with the first position and is not partially matched with the second position based on the distance between the first position and the second position, so that a series of first position clusters and a series of second position clusters are obtained; local assembly is conducted on second A type sequences and second B type sequences in the series of second position clusters, so that an assembly sequence is obtained; the assembly sequence is compared with the reference genome again, whether the comparison result of the assembly sequence is consistent with a comparison result for second A type sequences in the second position clusters is checked, if yes, it is proved that the first position and the second position are the gene fusion positions. According to the detection method, the true positive rate is high, and the result is more reliable.
Owner:天津诺禾致源生物信息科技有限公司

Method and device for simultaneously determining fetal haplotype and aneuploidy of chromosome

The invention provides a method and a device for simultaneously determining a fetal haplotype and the aneuploidy of chromosome. The method comprises the steps of (1) respectively extracting a first DNA, a second DNA and a third DNA from a body fluid sample of a pregnant woman and a sample of the father of a fetus, wherein the first DNA is a mixture of the DNA of the mother and the DNA of the fetus, the second DNA is a genome DNA of the mother, and the third DNA is the DNA of the father; (2) simultaneously or respectively sequencing the first DNA, the second DNA and the third DNA of at least one part so as to correspondingly obtain a first reading section, a second reading section and a third reading section; (3) respectively comparing the first reading section, the second reading section and the third reading section with a reference sequence, and performing (a) or (b) according to an obtained comparison result to screen out a specific polymorphic site; (4) determining the fetal nucleic acid content of the body fluid sample of the pregnant woman according to the quantity of the reading sections, which support the screened specific polymorphic site, in the comparison result of the first reading section; (5) simultaneously determining the fetal haplotype and the aneuploidy of the chromosome according to the comparison result and the fetal nucleic acid content.
Owner:TIANJIN MEDICAL LAB BGI +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products